Denik Pharma Grodif

​Grodif is a synthetic peptide developed by Denik Pharm Co Ltd, designed to inhibit myostatin (GDF-8), a protein that regulates muscle growth. By suppressing myostatin, Grodif aims to promote increased muscle mass and strength. It’s commonly used to address muscle-wasting conditions associated with aging, HIV, cancer, or other diseases.

Composition and Administration:

• Contents: Each vial contains 1 mg of Myostatin Propeptide (GDF-8).
• Reconstitution: Each package includes a 2 ml ampoule of sterile water for injection to reconstitute the lyophilized powder.
• Administration: Grodif is administered via intramuscular injection.

Dosage Guidelines:

• Initial Dose: 200 mcg per day, with the possibility to gradually increase.
• Maximum Dose: Up to 400 mcg per day, not exceeding 1 mg/kg of body weight in a single lifetime.

Storage Instructions:

• Pre-Reconstitution: Store at room temperature, away from heat and direct sunlight.
• Post-Reconstitution: Refrigerate between 2-8°C.

Contraindications:

• Acute critical illnesses such as heart or abdominal surgery, multiple accidental traumas, or respiratory failure.
• Active neoplasms.
• Proliferative or pre-proliferative diabetic retinopathy.
• Lactation.
• Patients with closed epiphyses.

Special Precautions:

• Intended for single-use; do not repeat the cycle once completed.
• Monitor for potential side effects and consult a healthcare professional before starting treatment.

Denik Pharm Co Ltd is recognized as a pioneer and market leader in the field of pharmaceutical-grade peptides and SARMs. The company is committed to ensuring the highest standards in manufacturing, offering pure and potent formulations.

For more detailed information, you can visit Denik Pharm’s official website: